An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid Arthritis

An Open-label, Single-arm, Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid Arthritis

A study comparing the usability of the Autoinjector and Pre-filled Syringe of SB4 in Subjects with Rheumatoid Arthritis.

Inclusion Criteria:

• Subjects are male or female aged 18-55 years at the time of signing the informed consent form.

Exclusion Criteria:

• Have been treated previously with monoclonal antibody agent including any tumour necrosis factor inhibitor except SB4.